Linda Mellbin

7PUBLICATIONS
40CO-AUTHORS
Major global burdens of diseaseCardiology (incl. cardiovascular diseases)NanomedicineCancer geneticsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2026
Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.

Eftychia Kontidou, Aida Collado, Rawan Humoud

|Aug 29, 2025
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease Results from the combined EUROASPIRE IV and V studies.

Safi Moayad Al-Azzawy, Mark Coyle, Guy De Backer

|Jul 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.

Robert F Storey, John Deanfield, Stefan James

|Oct 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction.

Nikolaus Marx, Lars Rydén, Massimo Federici

|Feb 28, 2024
Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials.

Linda G Mellbin, Deepak L Bhatt, Jens-Peter David

|Jan 05, 2024
Enhanced External Counterpulsation for Management of Postacute Sequelae of SARS-CoV-2 Associated Microvascular Angina and Fatigue: An Interventional Pilot Study.

Eline Wu, Ali Mahdi, Jannike Nickander

Pageof 2

Frequent Collaborators

2 joint publications

Lars Rydén

1 joint publications

Elena Fortin

1 joint publications

Ele Ferrannini

1 joint publications

Andrea Mari